Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
Q4 2022 vs. Q3 2022
How the institutions holding Scilex Holding Co changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 7 | +7 |
| Shares | 0 | 53.0K | +53.0K |
| Value | $0 | $240.1K | +$240.1K |
New holders (7)
Institutions that held Scilex Holding Co at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 16,220 | $64.7K | 0.00% |
| Ameritas Investment Partners, Inc. | 5,205 | $49.6K | 0.00% |
| Geode Capital Management, LLC | 11,817 | $47.0K | 0.00% |
| Millennium Management LLC | 11,187 | $45.0K | 0.00% |
| UBS Group AG | 7,275 | $29.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 837 | $3.00K | 0.00% |
| Affinity Asset Advisors, LLC | 463 | $1.85K | 0.00% |
Sold out (0)
Institutions that held Scilex Holding Co at the end of Q3 2022 and filed for Q4 2022 without it.
None.